|
Volumn 27, Issue 1, 2001, Pages 59-67
|
Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: Benefits of intensive care?
|
Author keywords
Chronic obstructive pulmonary disease patients; Intensive care unit; Invasive pulmonary aspergillosis; Mechanical ventilation; Outcome; Respiratory failure
|
Indexed keywords
AMIKACIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPHOTERICIN B DEOXYCHOLATE;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
AZTREONAM;
CEFEPIME;
CEFOTAXIME;
CEFTAZIDIME;
CEFUROXIME;
COTRIMOXAZOLE;
ERYTHROMYCIN;
GENTAMICIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
IMIPENEM;
ITRACONAZOLE;
OFLOXACIN;
PIPERACILLIN;
PIPERACILLIN PLUS TAZOBACTAM;
TEMOCILLIN;
VANCOMYCIN;
ADULT;
ADULT RESPIRATORY DISTRESS SYNDROME;
AGED;
ARTICLE;
ASPERGILLUS;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL ARTICLE;
FEMALE;
FORCED EXPIRATORY VOLUME;
FUNGUS CULTURE;
HUMAN;
INTENSIVE CARE UNIT;
LUNG ASPERGILLOSIS;
LUNG FUNCTION TEST;
LUNG MYCOSIS;
MALE;
NONHUMAN;
PNEUMONIA;
SEPTIC SHOCK;
THORAX RADIOGRAPHY;
TREATMENT INDICATION;
TREATMENT OUTCOME;
AGED;
ANTIFUNGAL AGENTS;
ASPERGILLOSIS;
BELGIUM;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
INTENSIVE CARE UNITS;
LENGTH OF STAY;
LUNG DISEASES, FUNGAL;
LUNG DISEASES, OBSTRUCTIVE;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
RESPIRATION, ARTIFICIAL;
RESPIRATORY INSUFFICIENCY;
RETROSPECTIVE STUDIES;
|
EID: 0035096462
PISSN: 03424642
EISSN: None
Source Type: Journal
DOI: 10.1007/s001340000768 Document Type: Article |
Times cited : (109)
|
References (43)
|